spec sheet10 rows
Pentedrone is a synthetic cathinone stimulant structurally related to methcathinone but bearing an extended propyl side chain. Unlike the entactogenic cathinones that trigger transporter-mediated serotonin release, pentedrone behaves as a non-releasing reuptake inhibitor of the norepinephrine and dopamine transporters, a mechanism it shares with the pyrovalerone cathinones; in vitro profiling shows potent catecholamine uptake blockade with negligible serotonergic release. This confers a comparatively pure, cocaine-like or amphetamine-like stimulant character together with strong reinforcing and compulsive-use potential. Case reports of intoxication and fatality involving pentedrone and its derivatives underscore meaningful cardiovascular and dependence risks.
- Strong stimulation and focus
- Euphoria and energy
- Appetite suppression
- Pure catecholamine reuptake blocker, non-releasing
- Cardiovascular strain and palpitations
- Compulsive redosing and dependence
- Insomnia and paranoia
- Risk of stimulant psychosis
Mechanism
Pentedrone acts mainly as a at the and transporters, keeping these catecholamines elevated in the ; it has little activity, which is why it feels like a plain, driving stimulant rather than an empathic entactogen. The strong dopamine involvement underlies its euphoria and its potential for compulsive redosing.
receptor fingerprint
Reuptake inhibitor
transporterReuptake inhibitor
Safetyrisks and cautions, not medical advice
As a potent stimulant it strains the cardiovascular system (fast heart rate, high blood pressure, palpitations), causes insomnia and appetite loss, and can drive compulsive binge use with paranoia and agitation. High or repeated dosing raises the risk of hyperthermia and stimulant psychosis. It is dangerous to combine with other stimulants or with MAOIs. Not medical advice.
Subjective profileweighing the evidence above
Nothing to recommend. It is a hard, purely catecholaminergic stimulant that drives compulsive binge use, palpitations, paranoia and stimulant psychosis, and case reports include fatalities. The missing serotonin warmth is not a feature; it just makes the redosing worse.
Resources
This entry is here for reference.
Research
- 2014first citedMonoamine transporter and receptor interaction profiles of a new series of designer cathinones.
- 2023most recentDo 2-(Benzoyl)piperidines Represent a Novel Class of hDAT Reuptake Inhibitors?
- 1.The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity
- 2.Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones
- 3.Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
- 4.Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
- 5.Do 2-(Benzoyl)piperidines Represent a Novel Class of hDAT Reuptake Inhibitors?
- 6.Fatal intoxication involving 4-methylpentedrone (4-MPD) in a context of chemsex.
6 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Does pentedrone feel like mephedrone?
Not really; it lacks the serotonin-driven warmth and is a plainer, more driving stimulant with a strong compulsive pull.
Why is it reinforcing?
Its strong dopamine reuptake inhibition produces euphoria that encourages compulsive redosing and binge use.
What are the main dangers?
Cardiovascular strain, sleep loss, paranoia, and at high or repeated doses hyperthermia and psychosis.
Adverse effects
- Cardiovascular strain and palpitations
- Compulsive redosing and dependence
- Insomnia and paranoia
- Risk of stimulant psychosis